Kestra Medical Technologies, Ltd. Income Statement

Income Statement Apr2024 Apr2025
Revenue & cost
Revenue 27.81M59.81M
Cost of Revenue 27.45M35.60M
Gross Profit 0.36M24.21M
Operating items
Research & Development 15.49M15.65M
Selling, General & Administrative 69.94M114.94M
Operating Expenses 85.42M130.59M
Operating Income -85.06M-106.38M
EBIT -85.06M-106.38M
Non-operating items
Interest & Investment Income 3.20M
Other Non Operating Income -2.80M3.56M
Non Operating Income -2.80M-2.77M
Net income details
EBT -94.10M-113.68M
Tax Provisions 0.02M0.14M
Profit After Tax -94.12M-113.81M
Income from Continuing Operations -94.12M-113.81M
Consolidated Net Income -94.12M-113.81M
Income towards Parent Company -94.12M-113.81M
Preferred Dividend Payments 6.72M12.32M
Net Income towards Common Stockholders -100.84M-126.14M
Additional items
EPS (Basic) -5.07-5.13
EPS (Weighted Average and Diluted) -5.07-5.13
Shares Outstanding (Weighted Average) 37.65M51.35M
Shares Outstanding (Diluted Average) 19.89M24.58M
EBITDA -85.06M-106.38M
Interest Expenses 6.23M7.73M